S651-1237 Screening compound: 2-methyl-8-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[(pyridin-2-yl)methyl]-2,8-diazaspiro[4.5]decane-3-carboxamide

S651-1237 Screening compound: 2-methyl-8-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[(pyridin-2-yl)methyl]-2,8-diazaspiro[4.5]decane-3-carboxamide
S651-1237 Screening compound: 2-methyl-8-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[(pyridin-2-yl)methyl]-2,8-diazaspiro[4.5]decane-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S651-1237
2-methyl-8-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[(pyridin-2-yl)methyl]-2,8-diazaspiro[4.5]decane-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S651-1237

Molecular Formula

C20H28N6O3S (C20 H28 N6 O3 S)

Compound Name

2-methyl-8-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[(pyridin-2-yl)methyl]-2,8-diazaspiro[4.5]decane-3-carboxamide

IUPAC name

2-methyl-8-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[(pyridin-2-yl)methyl]-28-diazaspiro[4.5]decane-3-carboxamide

SMILES

CN(CC(C1)(CC2)CCN2S(c2cn(C)cn2)(=O)=O)C1C(NCc1ncccc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.55

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

-0.361

Distribution Coefficient, logD

-0.424

Water Solubility, LogSw

-2.19

Polar Surface Area

81.924

Acid Dissociation Constant (pKa)

12.42

Base Dissociation Constant (pKb)

6.60

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.00

S651-1237 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
Targets:
  • Kinases
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S651-1237 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S651-1237?
Check Price and Availability of S651-1237, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S651-1237 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S651-1237
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S651-1237
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S651-1237 available by request